New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
10:03 EDTCHD, ITRI, DO, DELL, CG, MS, SLW, PDCE, EXPR, EA, HRC, PVA, MMC, GCI, AGNOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allergan (AGN) upgraded to Outperform from Market Perform at JMP Securities... Carlyle Group (CG) upgraded to Buy from Neutral at Citigroup... Dell (DELL) upgraded to Neutral from Sell at Citigroup... Express (EXPR) upgraded to Overweight from Neutral at JPMorgan... Gannett (GCI) upgraded to Buy from Neutral at Citigroup... Marsh & McLennan (MMC) upgraded to Buy from Neutral at Goldman... PDC Energy (PDCE) upgraded to Buy from Hold at Miller Tabak... Diamond Offshore (DO) upgraded to Outperform from Sector Perform at Iberia... Penn Virginia (PVA) upgraded to Outperform from Sector Perform at Howard Weil... Silver Wheaton (SLW) upgraded to Outperform from Neutral at Credit Suisse... Itron (ITRI) upgraded to Buy from Hold at Argus... Hill-Rom (HRC) upgraded to Conviction Buy from Buy at Goldman... Morgan Stanley (MS) upgraded to Neutral from Reduce at SunTrust... Church & Dwight (CHD) upgraded to Outperform from Underperform at CLSA... Electronic Arts (EA) upgraded to Buy from Neutral at Sterne Agee.
News For AGN;CG;GCI;EXPR;DELL;MMC;PDCE;DO;PVA;SLW;ITRI;HRC;MS;CHD;EA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
February 18, 2015
09:48 EDTAGNActavis Q4 'exceptional,' taking Allergan name 'wise,' says BMO Capital
BMO Capital says Actavis (ACT) is "firing on all cylinders" after reporting "exceptional" Q4 earnings on the strength of the company's North American Generics and International segment. BMO views the decision to adopt the Allergan (AGN) name as "wise" given the Botox maker's strong reputation. The firm keeps an Outperform rating on Actavis.
09:10 EDTPVAOn The Fly: Pre-market Movers
Subscribe for More Information
07:50 EDTAGNActavis CEO says company gave appropriate guidance to analysts
Actavis (ACT) CEO Saunders said he believes that the company did provide appropriate guidance to analysts ahead of its earnings beat. Saunders sees the Allergan (AGN) deal closing by the end of this quarter or early next quarter. Saunders says tying R&D to a percentage of revenue "makes no sense to me," noting that Actavis will spend about $1.7B on R&D next year. Saunders says will do acquisition if opportunity arises, but not planning for M&A right now. Actavis CEO Brent Saunders is speaking on CNBC.
07:42 EDTPVAPenn Virginia sees FY15 production 8.7-9.6 MMBOE
Sees FY15 daily production 23,800-26,300 BOEPD. Sees FY15 CapEx $2.95M-$345M. Sees drilling and completion capital expenditures to range between $6.0M-$7.5M per well for wells with two strings of casing, assuming 15 to 25 frac stages, and between $6.5M-$10.5M per well for 3-string wells, assuming 12 to 33 frac stages.
07:21 EDTMSJPMorgan, Citi top government report of riskiest banks, Reuters reports
Subscribe for More Information
07:01 EDTAGNActavis announces intention to adopt 'Allergan' corporate name
Subscribe for More Information
06:56 EDTDODiamond Offshore initiated with an Underperform at BMO Capital
Target $29.
06:51 EDTEXPRExpress upgraded on lower promotional activity at Piper Jaffray
Subscribe for More Information
06:34 EDTAGNActavis sees Allergan transaction completed in late Q1 or early Q2
06:08 EDTCGCarlyle Group upgraded to Buy from Neutral at Citigroup
Citigroup upgraded Carlyle Group to Buy saying it believes the company is entering a "robust" harvesting cycle. Citi says Carlyle is at a favorable inflection point and raised its price target for the stock to $32 from $30.50.
05:44 EDTEXPRExpress upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
February 17, 2015
18:06 EDTAGNPaulson & Co gives quarterly update on stakes
Subscribe for More Information
17:18 EDTAGNPershing Square gives quarterly update on stakes
NEW STAKES: Restaurant Brands International (QSR). INCREASED STAKES: Zoetis (ZTS), and Platform Specialty Products (PAH). DECREASED STAKES: Allergan (AGN). LIQUIDATED STAKES: None.
17:02 EDTAGNSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
13:52 EDTAGNEarnings Preview: Actavis near 52-week high ahead of Q4 earnings report
Subscribe for More Information
10:00 EDTMMCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:41 EDTMMCMarsh & McLennan upgraded to Buy from Neutral at Citigroup
Subscribe for More Information
07:22 EDTEAMitsubishi UFJ to hold a tour
Subscribe for More Information
07:15 EDTCHDConsumer Analyst Group of New York (CAGNY) to hold a conference
Subscribe for More Information
February 16, 2015
15:17 EDTDOTransocean slashes dividend to 60c from $3.00, says CEO leaving
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use